{"id":"https://openalex.org/W4392678863","doi":"https://doi.org/10.1158/0008-5472.c.6502059","title":"Data from Targeting the p53 Pathway in Retinoblastoma with Subconjunctival Nutlin-3a","display_name":"Data from Targeting the p53 Pathway in Retinoblastoma with Subconjunctival Nutlin-3a","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4392678863","doi":"https://doi.org/10.1158/0008-5472.c.6502059"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6502059","doi":"https://doi.org/10.1158/0008-5472.c.6502059","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6502059","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.c.6502059","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054120784","display_name":"Rachel Christine Brennan","orcid":"https://orcid.org/0000-0002-2090-4395","observed_orcids":["https://orcid.org/0000-0002-2090-4395"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel C. Brennan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046612625","display_name":"Sara Michele Federico","orcid":"https://orcid.org/0000-0002-5807-4876","observed_orcids":["https://orcid.org/0000-0002-5807-4876"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sara Federico","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111868310","display_name":"Cori L. Bradley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cori Bradley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079303145","display_name":"Jiakun Zhang","orcid":"https://orcid.org/0000-0002-7976-6425","observed_orcids":["https://orcid.org/0000-0002-7976-6425","https://orcid.org/0009-0001-5996-6593","https://orcid.org/0000-0002-6453-5413"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiakun Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076884713","display_name":"Jacqueline Flores\u2010Otero","orcid":"https://orcid.org/0000-0001-6501-9974","observed_orcids":["https://orcid.org/0000-0001-6501-9974"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacqueline Flores-Otero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Matthew Wilson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew Wilson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043293908","display_name":"Clinton F. Stewart","orcid":"https://orcid.org/0000-0002-1546-9720","observed_orcids":["https://orcid.org/0000-0002-1546-9720"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clinton Stewart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011790331","display_name":"Fangyi Zhu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fangyi Zhu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089893009","display_name":"Kip Guy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kip Guy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5023634801","display_name":"Michael A. Dyer","orcid":"https://orcid.org/0000-0003-4027-4850","observed_orcids":["https://orcid.org/0000-0003-4027-4850"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael A. Dyer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.017000000923871994,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10691","display_name":"Retinal Development and Disorders","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/retinoblastoma","display_name":"retinoblastoma","score":1.0},{"id":"https://openalex.org/keywords/nutlin-3a","display_name":"Nutlin-3a","score":0.9459999799728394},{"id":"https://openalex.org/keywords/p53-signaling-pathway","display_name":"p53 pathway","score":0.8690000176429749},{"id":"https://openalex.org/keywords/mdmx","display_name":"MDMX","score":0.921999990940094},{"id":"https://openalex.org/keywords/ophthalmic-formulations","display_name":"ophthalmic preparations","score":0.9120000004768372},{"id":"https://openalex.org/keywords/orthotopic-xenograft-model","display_name":"orthotopic xenograft","score":0.9459999799728394},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8080000281333923},{"id":"https://openalex.org/keywords/blood-ocular-barrier","display_name":"blood-ocular barrier","score":0.7789999842643738},{"id":"https://openalex.org/keywords/pediatric-eye-tumor","display_name":"pediatric eye cancer","score":0.5220000147819519}],"concepts":[{"id":"https://openalex.org/C2776577112","wikidata":"https://www.wikidata.org/wiki/Q500695","display_name":"Retinoblastoma","level":3,"score":0.7709228992462158},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3885749876499176},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.25621742010116577},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.21655112504959106},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.04772824048995972},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.c.6502059","doi":"https://doi.org/10.1158/0008-5472.c.6502059","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6502059","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/0008-5472.c.6502059.v1","doi":"https://doi.org/10.1158/0008-5472.c.6502059.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6502059.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6502059","doi":"https://doi.org/10.1158/0008-5472.c.6502059","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6502059","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2064110274","https://openalex.org/W2138772083","https://openalex.org/W4229457511","https://openalex.org/W2084069837","https://openalex.org/W4415958477","https://openalex.org/W2098342292","https://openalex.org/W7084038685","https://openalex.org/W2006133350","https://openalex.org/W941004563","https://openalex.org/W2144763821"],"abstract_inverted_index":{"Abstract":[0],"Retinoblastoma":[1],"is":[2,15,176],"a":[3,177,194],"rare":[4],"childhood":[5],"cancer":[6],"of":[7,21,25,35,45,56,69,85,132,141,153,171],"the":[8,18,54,79,83,86,94,123,137,164,169],"retina":[9],"that":[10,93,158,168],"begins":[11],"in":[12,17,82,89,104,145,187],"utero":[13],"and":[14,33,37,65,91,135,139,147,161,167,200],"diagnosed":[16],"first":[19],"years":[20],"life.":[22],"The":[23],"goals":[24],"retinoblastoma":[26,71,90,105,149,182],"treatment":[27,55,180],"are":[28],"ocular":[29,130],"salvage,":[30],"vision":[31],"preservation,":[32],"reduction":[34],"short-":[36],"long-term":[38],"side":[39],"effects":[40],"without":[41],"risking":[42],"mortality":[43],"because":[44,117],"tumor":[46],"dissemination.":[47],"To":[48],"identify":[49],"better":[50,179],"chemotherapeutic":[51],"combinations":[52],"for":[53,72,181,204,210],"retinoblastoma,":[57,116],"several":[58],"groups":[59],"have":[60,77],"developed":[61,128],"genetic":[62,146],"mouse":[63],"models":[64,68,152],"orthotopic":[66,150,189],"xenograft":[67,151],"human":[70,148,188],"preclinical":[73],"testing.":[74],"Previous":[75],"studies":[76,192],"implicated":[78],"MDMX":[80],"protein":[81],"suppression":[84],"p53":[87,165],"pathway":[88,166],"shown":[92],"MDM2/MDMX":[95],"antagonist,":[96],"Nutlin-3a,":[97,133],"can":[98],"efficiently":[99,162],"induce":[100],"p53-mediated":[101],"cell":[102,106],"death":[103],"lines.":[107],"However,":[108],"Nutlin-3a":[109],"cannot":[110],"be":[111],"administered":[112],"systemically":[113],"to":[114,198],"treat":[115],"it":[118],"has":[119],"poor":[120],"penetration":[121],"across":[122],"blood\u2013ocular":[124],"barrier.":[125],"Therefore,":[126],"we":[127,156],"an":[129],"formulation":[131,144],"Nutlin-3aOC,":[134],"tested":[136],"pharmacokinetics":[138],"efficacy":[140],"this":[142],"new":[143,195],"retinoblastoma.":[154,211],"Here,":[155],"show":[157],"Nutlin-3aOC":[159,172],"specifically":[160],"targets":[163],"combination":[170],"with":[173],"systemic":[174],"topotecan":[175],"significantly":[178],"than":[183],"currently":[184],"used":[185],"chemotherapy":[186],"xenografts.":[190],"Our":[191],"provide":[193],"standardized":[196],"approach":[197],"evaluate":[199],"prioritize":[201],"novel":[202],"agents":[203],"incorporation":[205],"into":[206],"future":[207],"clinical":[208],"trials":[209],"Cancer":[212],"Res;":[213],"71(12);":[214],"4205\u201313.":[215],"\u00a92011":[216],"AACR.":[217]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-03-13T00:00:00"}